The table below shows Terns Pharmaceuticals, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$82.18M
-$70.02M
-$67.39M
-$49.11M
-$41.83M
-$29.81M
Capital expenditure
$0.00
$42.00K
$52.00K
$275.00K
$340.00K
$584.00K
Investing cash flow
-$298.04M
-$12.41M
-$37.99M
-$22.27M
-$119.70M
$6.69M
Dividends paid
-
-
-
-
TERN operating cash flow (10-K history)
Terns Pharmaceuticals, Inc. reported operating cash flow of -$82.18M for fiscal year 2025. That is down 17.4% from -$70.02M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$29.81M (FY 2020) to -$82.18M. Figures come from the company's audited annual reports as filed with the SEC.
